Long-Term Survival after Kidney Transplantation This review discusses demographics,
survival, and risks in kidney transplantation since the mid-1990s. It addresses postoperative …

Ten years ago, a consensus report on the optimization of tacrolimus was published in this
journal. In 2017, the Immunosuppressive Drugs Scientific Committee of the International …

Background Use of cell-based medicinal products (CBMPs) represents a state-of-the-art
approach for reducing general immunosuppression in organ transplantation. We tested …

The kidney sessions of the 2017 Banff Conference focused on 2 areas: clinical implications
of inflammation in areas of interstitial fibrosis and tubular atrophy (i‐IFTA) and its relationship …

For three decades, the international Banff classification has been the gold standard for
kidney allograft rejection diagnosis, but this system has become complex over time with the …

Objective To assess whether reshaping of the immune balance by infusion of autologous
natural regulatory T cells (nTregs) in patients after kidney transplantation is safe, feasible …

Successful solid organ transplantation reflects meticulous attention to the details of
immunosuppression, balancing risks for graft rejection against risks for infection. The “net …

Tacrolimus is the mainstay immunosuppressant drug used after solid organ and
hematopoietic stem cell transplantation. Individuals who express CYP3A5 (extensive and …

Necroptosis | New England Journal of Medicine Skip to main content The New England Journal
of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology Clinical Medicine …

Solid organ transplantation (SOT) is a life-saving procedure and an established treatment for
patients with end-stage organ failure. However, transplantation is also accompanied by …